AI Verdict
RANI has stronger fundamentals based on our AI analysis.
RANI vs RAKR Fundamental Comparison
| Metric | RANI | RAKR |
|---|---|---|
| Revenue | $1.6M | $34,250.0 |
| Net Income | $-29.7M | $-929,521.0 |
| Net Margin | -1,817.1% | -2,713.9% |
| ROE | -89.9% | N/A |
| ROA | -50.6% | -892.1% |
| Current Ratio | 4.21x | 0.01x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-0.45 | $-0.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RANI vs RAKR: Frequently Asked Questions
Is RANI or RAKR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RANI has stronger fundamentals. RANI is rated SELL (48% confidence) while RAKR is rated STRONG SELL (95% confidence). This is not investment advice.
How does RANI compare to RAKR fundamentally?
Rani Therapeutics Holdings, Inc. has ROE of -89.9% vs Rainmaker Worldwide Inc.'s N/A. Net margins are -1,817.1% vs -2,713.9% respectively.
Which stock pays higher dividends, RANI or RAKR?
RANI has a dividend yield of N/A or no dividend while RAKR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RANI or RAKR for long term?
For long-term investing, consider that RANI has SELL rating with 48% confidence, while RAKR has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RANI vs RAKR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RANI vs RAKR, the AI consensus favors RANI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.